Antimalarials and electrocardiographic alterations: New data bring confidence Dr. Kamal Kant Kohli5 Jun 2022 8:00 PM ISTPrevious findings on the link between hydroxychloroquine and risk of arrhythmia have been contradictory, with low-level evidence-based results. To...
India-made stimulants, COVID-related drugs dominate illegal imports in Switzerland Ruchika Sharma22 Feb 2022 9:00 AM ISTNew Delhi: A large number of illegally imported drugs in Switzerland have been found to have been sent from India, including medicines connected with...
Medical Bulletin 30/December/2021 Dr. Nandita Mohan30 Dec 2021 6:12 PM ISTHere are top Medical stories of the dayOmega-3 fish oil supplements do not help prevent depressionResults from the largest clinical trial of its kind...
Why smoking cessation should be promoted in systemic lupus erythematosus patients? MD Editorial Team22 Dec 2021 9:00 AM ISTAccording to a new study, smoking is connected with higher B cell-activating factor (BAFF) and decreased interferon (IFN-) levels, as well as an...
Researchers raise red flag over prescribing hydroxychloroquine for Covid-19 MD Bureau1 Sept 2021 6:21 PM ISTNew York: Hydroxychloroquine (HCQ) -- approved by the US Food and Drug Administration (FDA) to treat or prevent malaria as well as some auto-immune...
Ophthalmological monitoring of HCQ and chloroquine - Updated recommendations by RCOphth Dr Manoj Kumar Nayak14 July 2021 9:00 AM ISTHydroxychloroquine and chloroquine ophthalmological monitoring recommendations have been updated and released by the Royal College of...
Antimalarial drug mefloquine promising in the battle against COVID-19, finds study Hina Zahid3 July 2021 9:00 AM ISTThe study must be succeeded by trials, but there is a hope that mefloquine can become a drug used to effectively treat patients with...
IPCA Lab gets CDSCO panel nod for phase 3 trial of HCQ as add-on therapy in type 2 diabetes Medical Dialogues Team27 Jun 2021 11:30 AM ISTNew Delhi: IPCA Laboratories has secured the Central Drugs Standard Control Organization (CDSCO) panel nod to conduct a Phase III clinical trial of...
Use of ivermectin, hydroxychloroquine, favipiravir dropped from new COVID-19 treatment guidelines Ruchika Sharma9 Jun 2021 3:40 PM ISTNew Delhi: The Union Health Ministry on Monday dropped the use of ivermectin, hydroxychloroquine, and the anti-viral favipiravir from its COVID-19...
Long term HCQS use safe and Does not Raise all cause mortality, says Study MD Bureau25 May 2021 9:45 AM ISTAs a result of the SARS-CoV-2 outbreak, hydroxychloroquine (HCQ) has been widely discussed throughout the scientific community. The potential...
Joint statement on hydroxychloroquine use with respect to retinal toxicity Medha Baranwal3 March 2021 8:45 AM ISTUSA: Four renowned medical societies have released a joint statement on the use of hydroxychloroquine with respect to retinal toxicity. The...
WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 Hina Zahid2 March 2021 7:15 AM ISTThe anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline...
